Systane Ultra Lubricant Eye Drops: Dry-eye relief for everyday comfort

Responsible: ad hoc news B2B & Pro Desk. Reviewed prior to publication on June 13, 2026 at 2:57 PM ET. Details in the imprint.

Systane Ultra Lubricant Eye Drops from Alcon are designed to relieve the burning and irritation caused by dry eye, using a combination of polyethylene glycol and propylene glycol as lubricants alongside the gelling agent HP-Guar to stabilize the tear film. The drops are sold over the counter in the U.S. in both multi-dose bottles and preservative-free vials, making them easy to integrate into a daily eye-care routine for people who experience intermittent or chronic dryness. For many consumers, the product sits between basic artificial tears and prescription therapies, targeting those who want more than simple saline but do not yet require a prescription solution.

What Systane Ultra is designed to do

Alcon positions Systane Ultra as a high-performance lubricant drop formulated to provide extended relief for dry-eye symptoms such as burning, stinging, and irritation, which can be triggered by factors like prolonged screen time, air conditioning, or contact lens wear. According to Alcon’s product information, the formula uses HP-Guar to create a gel-like matrix on the eye that interacts with the natural tear film, aiming to reduce evaporation and support a smoother ocular surface. The active ingredients polyethylene glycol 400 (0.4 percent) and propylene glycol (0.3 percent) act as demulcents, coating the eye to relieve discomfort in people with mild to moderate dry eye. Systane Ultra is indicated as a temporary relief product and is generally used as needed throughout the day, with labeling advising users to follow package directions and consult an eye-care professional if symptoms persist.

The product is typically preservative-containing in its standard multi-dose bottle format, using polyquad (polyquaternium-1) as the preservative, while Alcon also offers preservative-free single-use vials for patients who are sensitive to preservatives or who use drops very frequently. Polyquad is commonly used in ophthalmic products and is considered less likely than older preservatives such as benzalkonium chloride to disrupt the ocular surface when used as directed. For consumers who need to instill drops multiple times a day, the preservative-free option can be appealing, even though it tends to be more expensive per milliliter than the preserved bottle.

Systane Ultra is not marketed as a contact lens rewetting drop, and Alcon’s labeling advises users to remove contact lenses prior to use unless otherwise directed by an eye-care professional. Instead, the product is positioned more broadly for people with dry-eye symptoms regardless of contact lens use, from office workers spending hours in front of monitors to older adults experiencing age-related tear-film instability. The formula’s relatively low viscosity makes it less likely to cause prolonged blurring of vision compared with some gel drops, which can matter for users who need to continue working or driving shortly after instillation.

In terms of safety and tolerability, Systane Ultra is generally well tolerated when used as directed, although, as with any ophthalmic product, individual reactions can vary, and package labeling highlights potential signs of intolerance such as eye pain, changes in vision, or continued redness that warrant medical evaluation. Independent consumer and professional reviews tend to highlight fast symptom relief and comfort at instillation, while some users note that they prefer thicker formulations at night if their dry eye is severe. For people with more advanced dry eye or underlying inflammatory or autoimmune conditions, eye-care practitioners may combine Systane Ultra with prescription medications or recommend alternative therapies as part of a broader treatment plan.

Position in Alcon’s dry-eye portfolio and U.S. availability

Within Alcon’s Systane-branded range, Systane Ultra sits alongside variants such as Systane Complete and Systane Hydration, each targeting slightly different aspects of tear-film dysfunction and patient preference. Systane Complete, for example, is marketed toward coverage of all major components of the tear film, while Systane Hydration emphasizes moisture retention for patients with more pronounced symptoms. Systane Ultra’s balance between viscosity and clarity makes it something of a generalist in the lineup, which helps explain its broad positioning in both consumer advertising and professional recommendations.

In the U.S. market, Systane Ultra is widely distributed through mass retailers, pharmacies, grocery chains, and online platforms, including major e-commerce sites and Alcon’s own retailer partners. Pack sizes commonly include 10 ml multi-dose bottles and boxes of single-use vials, although exact volumes and configurations can vary by retailer and over time. Pricing information can shift with promotions, but Systane Ultra typically occupies a mid-to-premium price tier within the artificial tears category, reflecting its brand positioning and formulation complexity relative to basic lubricating drops. Because it is an over-the-counter product, consumers can purchase it without a prescription, though eye-care professionals often guide product choice based on individual symptom profiles and lifestyle factors.

For Alcon, Systane-branded products form a significant part of its Vision Care segment, which includes over-the-counter dry-eye therapies, contact lenses, and related solutions. While the company does not always break out revenue by individual OTC brand in public filings, it describes Systane as one of the leading global dry-eye franchises, which suggests that Systane Ultra and its sister products play a notable role in driving recurring consumer sales. Given the rising prevalence of digital eye strain and aging demographics, demand for lubricating eye drops has been a structural tailwind for companies like Alcon.

For shoppers, it makes sense to compare preservative-containing and preservative-free formats, check package sizes, and consult an eye-care provider if symptoms are frequent or severe, especially since dry eye can sometimes signal underlying ocular surface disease. From a corporate perspective, Systane Ultra underscores how Alcon leverages its clinical and manufacturing expertise from prescription ophthalmology into mass-market consumer products, complementing its surgical and professional offerings. Shares of Alcon Inc. (CH0432492467, ticker ALC) last traded on the New York Stock Exchange at a price level reported in recent market data services, providing investors with exposure to both its surgical ophthalmology and consumer eye-care businesses.

This article was created with a.i. assistance and editorially reviewed. Product information is provided without warranty; prices and availability may change at any time. Not investment advice, not a buy or sell recommendation. Trading in securities carries risks up to the total loss of capital.